COVID-19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Both sexes; aged 18 to 75 years; normal or corrected vision; with previous diagnosis of COVID-19; Only for study 3 - the participant needs to be clinically stable; oxygen saturation > 93%; respiratory rate of at least 12-20 breaths per minute (pmI); heart rate of 60 to 110 breaths per minute (bpm)
Exclusion criteria
Exclusion criteria: participants who have inability to fully or fully understand the instruments used in this project; participants with myopathies; diseases with peripheral demyemyellinization; malnutrition; neoplasms in treatment; anorexia; chronic kidney diseases; liver disease; or any other disease that promotes sarcopenia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant improvement in functional capacity is expected when compared before and after the intervention period, through the tests: Sit and Stand up and Timed Up and Go (TUG);Significant improvement in the strength of the muscles worked is expected when compared before and after the treatment period, by means of the maximum repetition 1 test (1RM);It is expected to find a reduction in fatigue and pain, when compared before and after the treatment period, through the fatigue assessment scale and the visual analog scale (VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to improve the subjective perception of quality of life after COVID, when compared before and after the treatment period, through the EQ-5D questionnaire, especially in the domains of physical and mental health;;A significant improvement in sleep quality is expected when compared before and after the intervention, using the Pittsburgh questionnaire. | — |
Countries
Brazil
Contacts
Universidade Presbiteriana Mackenzie